Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-03-05 @ 8:51 AM
Study NCT ID:
NCT04588051
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-30
First Post:
2020-10-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib in Hepatocellular Carcinoma
Sponsor:
Stephen Chan Lam
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCC063
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None